[Ip-health] The cost of patent protection and mismarketing drugs

Dean Baker Dean.Baker1 at verizon.net
Fri Apr 24 02:42:19 PDT 2015


we calculate the cost in the form of increased mortality and morbidity 
from 5 cases of drugs where there
was either a court ruling or settlement involving accusations of 
concealing or misrepresenting information
on safety and effectiveness. The cost from these five drugs alone 
(admittedly the most egregious examples)
was comparable to the amount that the industry claimed to be spending on 
research

http://www.cepr.net/index.php/publications/reports/patent-monopolies-and-the-costs-of-mismarketing-drugs

-- 
Dean Baker (baker at cepr.net)
Co-Director
Center for Economic and Policy Research 1611 Connecticut Ave., NW
Washington, DC 20009
202-293-5380 (ext 114)
202-332-5218 (H)
www.cepr.net





More information about the Ip-health mailing list